BDX

Becton, Dickinson and Company

Healthcare · NYSE · Market cap $48.5bn

$191.75

as of 16 Oct 2026, 2% below its 52-week high

Screens as reasonably placed to keep growing its dividend, though with some cut-risk signals worth watching. Its valuation looks somewhat extended against its own history.

These scores are a resilience check on the dividend, not a recommendation to buy or sell. They are not financial advice.

Trailing yield: 2.07%Last 12 months of regular payments at today's price
Forward yield: 2.25%Each payment expected in the next 12 months, not the latest one doubled
Earnings cover: 0.53×Pays 187% of earnings
Cash cover: 1.5×Free cash flow over dividends paid
5y dividend growth: +4.8% a yearNo cut since FY2008
Next ex-dividend date: Estimated8 Dec 2026Quarterly dividend of about $0.89

Compared with US companies in Healthcare (47)

Trailing yield is higher than 34 of the 46 other US companies in Healthcare.
5y dividend growth (as paid) is higher than 25 of the 38 other US companies in Healthcare with a 5y growth figure.

Quality

Moderate

Capacity to keep growing the dividend

Risk

Moderate

Signals of dividend-cut pressure

Trim

Moderate

How extended the valuation looks

Why Risk is 50

BDX against US companies in Healthcare (47)

Valuation against its own history

As of the last reported period (30 Jun 2026). P80 means the figure is higher than 80% of BDX’s past readings.

P/E27.6×P67, neutral for this measure
Yield2.5%P87, good for this measure
FCF payout67.6%P60, neutral for this measure
Net debt / EBITDA12.89P8, good for this measure
DGR 5y8.3%P70, good for this measure
ROIC1.2%P92, good for this measure

Open valuation history

Forecast your income with the BDX dividend calculator

Inspect surfaces history; it does not predict the future. Nothing here is financial advice or an instruction to buy or sell. Always do your own research. See the Terms of Service.